Updated May 2 at 11:26pm
Biotechnology
53 results total, viewing 1 - 10
For all the fuss over tax inversions and the Obama administration’s efforts to prevent them, shares of companies that were able to plow their inversion deals through to the finish line and lock in all those (some would call them nefarious) benefits have to be soaring, right? Not so for Medtronic. more
Rhode Island ranked 33rd in the nation for venture-capital investment in the first quarter, which featured only one deal - $5 million to IlluminOss Medical Inc. more
(Updated 9:57 a.m. and 1:43 p.m.) Nabsys has completed a financial restructuring and is back in business, operating out of its Clifford Street office. more
With equally strong interests in biology and visual arts, Rebecca Wojciechowicz enjoyed a quintessentially Brown undergraduate experience, parlaying the open curriculum into a dual concentration that she completed in 2014. But then she stayed to earn a master’s degree in biotechnology. more
In one room at the Cambridge Innovation Center in Massachusetts, a large table is shared by a half-dozen people, plugged into laptops and oblivious to passing visitors. In a connecting hallway, overstuffed couches attract workers who would rather … more
Medtronic PLC plans to consolidate its operations in Mansfield. Company spokesman Fernando Vivanco said Medtronic will consolidate its buildings from four to three. more
A project about creating biodegradable plastics – also known as bioplastics – out of cornstarch, potatoes and milk has made a biotechnology class at East Greenwich High School a finalist in Samsung’s “Solve for Tomorrow” contest. more
After sitting out for most of the biotech acquisition frenzy of 2015, Amgen Inc. is ready to do a deal. more
When the University of Rhode Island’s Department of Cell and Microbiology saw an opportunity to help address the needs of Rhode Island’s biotech and pharmaceutical companies and satisfy student interest, it ran with it. more
Medtronic PLC, the world’s biggest maker of heart-rhythm devices, met third-quarter profit estimates as its newest products continue to take market share from rivals. more
1 | 2 | 3 | 4 | 5 | 6 Next »